Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1988 1
1990 2
1991 1
1992 3
1993 2
1994 1
1995 2
1996 1
1997 1
1998 3
1999 1
2000 5
2001 3
2002 11
2003 8
2004 19
2005 18
2006 16
2007 14
2008 22
2009 22
2010 13
2011 11
2012 12
2013 9
2014 9
2015 6
2016 4
2017 8
2018 6
2019 14
2020 8
2021 18
2022 13
2023 12
2024 14
2025 5
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Results by year

Filters applied: . Clear all
Page 1
Phase 1 Study of [177Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results.
Mittra ES, Solnes LB, van der Veldt AAM, Wong J, Aloj L, Heinrich MC, Chen CT, Rowe SP, Brabander T, Pacey S, Aimone P, Pathak D, Blumenstein L, Liu Y, Iagaru A. Mittra ES, et al. Among authors: heinrich mc. J Nucl Med. 2026 Feb 2;67(2):262-268. doi: 10.2967/jnumed.125.270411. J Nucl Med. 2026. PMID: 41344852 Free PMC article. Clinical Trial.
Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE.
Heinrich MC, Blay JY, Gelderblom H, George S, Schöffski P, von Mehren M, Zalcberg JR, Jones RL, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Boye K, Goldstein D, Sánchez C, Siontis BL, Cox P, Davis E, Sherman ML, Ruiz-Soto R, Bauer S. Heinrich MC, et al. J Clin Oncol. 2025 Jul 10;43(20):2239-2244. doi: 10.1200/JCO-24-02818. Epub 2025 May 23. J Clin Oncol. 2025. PMID: 40408605 Free PMC article. Clinical Trial.
Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results.
Cortes JE, Lang F, Rea D, Hochhaus A, Breccia M, Goh YT, Heinrich MC, Hughes TP, Janssen JJWM, le Coutre P, Minami H, Sasaki K, DeAngelo DJ, Sanchez-Olle G, Pognan N, Cao M, Hoch M, Mauro MJ. Cortes JE, et al. Among authors: heinrich mc. Leukemia. 2025 May;39(5):1124-1134. doi: 10.1038/s41375-025-02592-9. Epub 2025 Apr 9. Leukemia. 2025. PMID: 40204896 Free PMC article. Clinical Trial.
Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results.
Hochhaus A, Kim DW, Cortes JE, Sasaki K, Mauro MJ, Hughes TP, Breccia M, Talpaz M, Minami H, Goh YT, DeAngelo DJ, Lang F, Ottmann O, Heinrich MC, Gomez Garcia de Soria V, le Coutre P, Sanchez-Olle G, Cao M, Pognan N, Kapoor S, Hoch M, Rea D. Hochhaus A, et al. Among authors: heinrich mc. Leukemia. 2025 May;39(5):1114-1123. doi: 10.1038/s41375-025-02578-7. Epub 2025 Apr 9. Leukemia. 2025. PMID: 40204892 Free PMC article. Clinical Trial.
The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with KIT exon 11 + 17/18 mutations.
George S, Blay JY, Chi P, Jones RL, Serrano C, Somaiah N, Gelderblom H, Zalcberg JR, Reichmann W, Sprott K, Cox P, Sherman ML, Ruiz-Soto R, Heinrich MC, Bauer S. George S, et al. Among authors: heinrich mc. Future Oncol. 2024;20(27):1973-1982. doi: 10.1080/14796694.2024.2376521. Epub 2024 Sep 4. Future Oncol. 2024. PMID: 39229786 Free PMC article.
292 results